Lexaria Bioscience (LEXX) Return on Equity [ROE] (2018 - 2026)
Lexaria Bioscience (LEXX) reported Return on Equity [ROE] of -141.40% for fiscal Q3 2026 (quarter ended May 31, 2026), up 49.77 percentage points from -191.17% a year earlier and up 36.32 percentage points from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Return on Equity [ROE] (2018 - 2026) Analysis & Trends
For FY2025 (ended Aug 31, 2025), Lexaria Bioscience posted Return on Equity [ROE] of -223.72%, down 111.35 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of -190.74 percentage points (FY2020 to FY2025).
- By fiscal year, Return on Equity [ROE] came in at -112.36% in FY2024 (+17.82 pp), -130.18% in FY2023 (-58.83 pp), -71.35% in FY2022 (-65.95 pp) and -5.40% in FY2021 (+27.57 pp).
- The fiscal Q3 2026 figure ranks as the highest quarterly Return on Equity [ROE] since fiscal Q2 2025.
- Year over year, Return on Equity [ROE] gained in three of the last eight quarters, with an average year-over-year change of -53.64 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was fiscal Q4 2024 (a gain of 116.32 percentage points); the low point was fiscal Q4 2025 (a drop of 238.89 percentage points).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -177.72% (Q2 2026), -287.56% (Q1 2026) and -292.08% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.64 Bn | 1,139.22 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 640.54 Bn | 559.06 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 501.78 Bn | 474.89 Bn | 12.70 Bn | - |
| 4 | Merck | 374.95 Bn | 329.32 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 302.43 Bn | 266.42 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 268.31 Bn | 241.99 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 242.70 Bn | 198.10 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 193.64 Bn | 167.84 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 172.34 Bn | 118.98 Bn | 10.94 Bn | 4.97% |
| 10 | Lexaria Bioscience | 2.55 Mn | -12.71 Mn | - | -141.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -141.40% |
| Feb 28, 2026 | -177.72% |
| Nov 30, 2025 | -287.56% |
| Aug 31, 2025 | -292.08% |
| May 31, 2025 | -191.17% |
| Feb 28, 2025 | -116.31% |
| Nov 30, 2024 | -85.97% |
| Aug 31, 2024 | -53.19% |
| May 31, 2024 | -46.45% |
| Feb 29, 2024 | -90.14% |
| Nov 30, 2023 | -163.53% |
| Aug 31, 2023 | -169.51% |
| May 31, 2023 | -141.35% |
| Feb 28, 2023 | -132.74% |
| Nov 30, 2022 | -105.41% |
| Aug 31, 2022 | -40.72% |
| May 31, 2022 | -46.93% |
| Feb 28, 2022 | -42.95% |
| Nov 30, 2021 | -37.12% |
| Aug 31, 2021 | -48.19% |
API Access
Lexaria Bioscience Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();